Clinical Trials Browser

OTHER × Breast Neoplasms, Male × Immunotherapy × Clear all

NCT03387553 2026-05-07

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT03384914 2026-03-06

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms, Neoplasm, Residual, Breast Neoplasms, Male